Supported content
Independently created content that is financially supported by our commercial partners. The Pharmaceutical Journal retains editorial responsibility.

Pain management and the role of pharmacy (video)

In this video, Gino Martini, chief scientist at the Royal Pharmaceutical Society, outlines evidence-based management options for acute, chronic and chronic primary pain to address misconceptions and promote best practice in pharmacy.

Article Supported By
Gino Martini

On 4 August 2020, the National Institute for Health and Care Excellence (NICE) published draft guidance on the management of chronic primary pain that stated that in place of common pain medicines — such as paracetamol; non-steroidal anti-inflammatory drugs, including aspirin and ibuprofen; benzodiazepines; and opioids — non-pharmacological options, such as cognitive behavioural therapy or acupuncture, should be offered to patients with chronic primary pain.

In this video, Gino Martini, chief scientist at the Royal Pharmaceutical Society, outlines the evidence-based management options for acute, chronic and chronic primary pain to address misconceptions and promote best practice in pharmacy.

A full list of the references and guidelines referred to in this video can be found below.

For more free and open resources developed to help pharmacy teams better serve patients seeking advice for acute pain, see our Pharmacy Learning Centre.

Video produced by Geoff Marsh.

References

British Pain Society

Contemporary guidance, supported by available evidence, on clinical and other pain matters can be found on the British Pain Society website.

Cochrane review

Moore R, Wiffen P, Derry S et al. Non-prescription (OTC) oral analgesics for acute pain: an overview of Cochrane reviews. Cochrane Database Syst Rev 2015;4(11):CD010794. doi: 10.1002/14651858.CD010794.pub2

Faculty of Pain Medicine of the Royal College of Anaesthatists

Guidelines

Conducting quality consultations in pain medicine. 2018. Available at: https://fpm.ac.uk/sites/fpm/files/documents/2019-08/Conducting%20Quality%20Consultations%202018.pdf (accessed December 2020)

Resources

Opioids Aware. Available at: https://www.fpm.ac.uk/opioids-aware (accessed December 2020)

Learning

Health Education England e-Learning Pain Management programme. Available at: https://www.e-lfh.org.uk/programmes/pain-management/ (accessed December 2020)

National Institute for Health and Care Excellence

Clinical Knowledge Summaries

Analgesia — mild-to-moderate pain. 2020. Available at: https://cks.nice.org.uk/analgesia-mild-to-moderate-pain#!scenarioRecommendation:1 (accessed December 2020)

Back pain — low (without radiculopathy). 2020. Available at: https://cks.nice.org.uk/back-pain-low-without-radiculopathy#!scenario (accessed December 2020)

Dysmenorrhea — primary dysmenorrhea. 2018. Available at: https://cks.nice.org.uk/dysmenorrhoea#!scenario (accessed December 2020)

NSAIDs — prescribing issues. 2019. Available at: https://cks.nice.org.uk/nsaids-prescribing-issues#!scenarioRecommendation:5 (accessed December 2020)

Sprains and strains — management. 2020. Available at: https://cks.nice.org.uk/topics/sprains-strains/management/management/ (accessed December 2020)

Evidence summary

Acute use of nonsteroidal anti-inflammatory drugs (NSAIDs) for people with or at risk of COVID-19. 2020. Available at: https://www.nice.org.uk/advice/es23/resources/covid19-rapid-evidence-summary-acute-use-of-nonsteroidal-antiinflammatory-drugs-nsaids-for-people-with-or-at-risk-of-covid19-pdf-1158174128581 (accessed December 2020)

Draft guidelines

Chronic pain in over 16s: assessment and management. 4 August 2020. Available at: https://www.nice.org.uk/guidance/GID-NG10069/documents/draft-guideline (accessed December 2020)

Guidelines

CG150: Headaches in over 12s: diagnosis and management. 2015. Available at: https://www.nice.org.uk/guidance/cg150/chapter/Recommendations#management-2 (accessed December 2020)

NG59: Lower back pain and sciatica in over 16s: assessment and management. 2020. Available at: https://www.nice.org.uk/guidance/ng59/chapter/Recommendations (accessed December 2020) 

Last updated
Citation
The Pharmaceutical Journal, December 2020;Online:DOI:10.1211/PJ.2020.20208681